Filter
Reset all

Subjects

Content Types

Countries

AID systems

Data access

Data access restrictions

Database access

Data licenses

Data upload

Enhanced publication

Institution responsibility type

Institution type

Keywords

PID systems

Provider types

Quality management

Repository languages

Software

Syndications

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 4 result(s)
>>>>!!!<<<<As of March 28, 2016, the 'NSF Arctic Data Center' will serve as the current repository for NSF-funded Arctic data. The ACADIS Gateway http://www.aoncadis.org is no longer accepting data submissions. All data and metadata in the ACADIS system have been transferred to the NSF Arctic Data Center system. There is no need for you to resubmit existing data. >>>>!!!<<<< ACADIS is a repository for Arctic research data to provide data archival, preservation and access for all projects funded by NSF's Arctic Science Program (ARC). Data include long-term observational timeseries, local, regional, and system-scale research from many diverse domains. The Advanced Cooperative Arctic Data and Information Service (ACADIS) program includes data management services.
The Cancer Immunome Database (TCIA) provides results of comprehensive immunogenomic analyses of next generation sequencing data (NGS) data for 20 solid cancers from The Cancer Genome Atlas (TCGA) and other datasource. The Cancer Immunome Atlas (TCIA) was developed and is maintained at the Division of Bioinformatics (ICBI). The database can be queried for the gene expression of specific immune-related gene sets, cellular composition of immune infiltrates (characterized using gene set enrichment analyses and deconvolution), neoantigens and cancer-germline antigens, HLA types, and tumor heterogeneity (estimated from cancer cell fractions). Moreover it provides survival analyses for different types immunological parameters. TCIA will be constantly updated with new data and results.